Clinical Trial Update: 99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

View source ↗

Summary

This clinical trial is evaluating a technetium-99m labeled FAP-targeted molecular probe for early tumor diagnosis, and the study is currently recruiting. It tar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• 99mTc-labeled FAP-targeted molecular probe (Technetium-99m labeled fibroblast activation protein-targeted molecular probe)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Head and Neck Tumor, Lung Cancer | Status: RECRUITING